Topical imiquimod monotherapy for indolent primary cutaneous B-cell lymphomas: a single-institution experience.

Hwang, S; Johnson, A; Fabbro, S; Hastings, J; Haverkos, B; Chung, C; Porcu, P; William, B

Hwang, S; Johnson, A; Fabbro, S; Hastings, J; Haverkos, B; Chung, C; Porcu, P; William, B.

Afiliação

Hwang S; Division of Hematology, Ohio State University, Columbus, OH, USA.
Johnson A; Division of Hematology, Ohio State University, Columbus, OH, USA.
Fabbro S; Division of Dermatology, Department of Medicine, Ohio State University, Columbus, OH, USA.
Hastings J; Division of Dermatology, Department of Medicine, Ohio State University, Columbus, OH, USA.
Haverkos B; Blood Cancer and BMT Program, University of Colorado School of Medicine, Aurora, CO, USA.
Chung C; Division of Dermatology, Department of Medicine, Ohio State University, Columbus, OH, USA.
Porcu P; Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Sidney Kimmel Cancer Center at Jefferson, Thomas Jefferson University, Philadelphia, PA, USA.
William B; Division of Hematology, Ohio State University, Columbus, OH, USA.

Br J Dermatol ; 183(2): 386-387, 2020 08.

Article em En | MEDLINE | ID: mdl-32078154

Assuntos

Antineoplásicos; Linfoma de Células B; Neoplasias Cutâneas; Aminoquinolinas/uso terapêutico; Antineoplásicos/uso terapêutico; Humanos; Imiquimode/uso terapêutico; Linfoma de Células B/tratamento farmacológico; Neoplasias Cutâneas/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Linfoma de Células B / Antineoplásicos Limite: Humans Idioma: En Revista: Br J Dermatol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google